Clinical trial
Prevention of Docetaxel Induced Dacryostenosis
NCT00266838 · Universitaire Ziekenhuizen KU Leuven, Other · Completed
Key facts
| NCT number | NCT00266838 |
|---|---|
| Title | Prevention of Docetaxel Induced Dacryostenosis |
| Official title | A Double Blind Interventional Study of the Efficacy of Topical Eye Treatment in the Prevention of Docetaxel Induced Dacryostenosis |
| Lead sponsor | Universitaire Ziekenhuizen KU Leuven, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Epiphora |
| Intervention type | Drug |
| Interventions | Maxidex, Lacrystat |
| Enrollment | 20 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Dec 19, 2005 |
| Last update posted | Jun 28, 2010 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: